Company profile
Picard Medical, Inc.
AMEX: PMI · Healthcare · Medical - Devices
#711 of 1,418 Healthcare companies by revenue59th-percentile growth
EA Score
25DFH 35DQ 4GM —SS 44
v0.1 · 55/100 weight · provisional
↑ market scale, Piotroski F · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$5.5M
Rev growth YoY (TTM)
+80.7%
Net income (FY)
-$27.0M
Employees
75
as of 2026-08-13
Market cap
$350.2M
as of 2026-08-13
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$4.9M$4.9M2025
Net income-$27.0M-$27.0M2025
Operating income-$13.3M-$13.3M2025
Total assets$22.5M$22.5M2025
Liabilities$18.8M$18.8M2025
Equity$3.8M$3.8M2025
Revenue by segment
Filed disclosures · FY2025
By product
Product73%
Rentals27%
By geography
Not disclosed.
The read
What is Picard Medical, Inc.’s revenue?
Picard Medical, Inc. booked $4.9M in FY2025 revenue, growing 13% year over year — about the middle of the pack among Healthcare companies we track, at a -546.6% net margin.
Peers · Healthcare
Banyan Corp.——Procyon Corporation——InMed Pharmaceuticals Inc.45DLucid Diagnostics Inc.35DPrime Medicine, Inc.37DHealthy Extracts Inc.69BNeighbors
Pima →Key facts
CEORichard Fang
SectorHealthcare
IndustryMedical - Devices
HeadquartersTucson, AZ
ExchangeAMEX: PMI
Employees75
IPO date2025-08-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.